Trials / Conditions / Malignant Uterine Neoplasm

Malignant Uterine Neoplasm

10 registered clinical trials studyying Malignant Uterine Neoplasm — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematolog NCT07118176	Jonsson Comprehensive Cancer Center	Phase 1
Recruiting	Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients Wit NCT06492070	Emory University	Phase 2
Recruiting	PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorecta NCT04329494	City of Hope Medical Center	Phase 1
Active Not Recruiting	Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors NCT04634617	M.D. Anderson Cancer Center	—
Suspended	Paclitaxel Therapeutic Drug Monitoring in Cancer Patients NCT03987555	Wake Forest University Health Sciences	—
Recruiting	Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial NCT05049538	M.D. Anderson Cancer Center	—
Terminated	Sacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Lo NCT04066894	M.D. Anderson Cancer Center	Phase 2
Completed	EHealth Mindful Movement and Breathing in Improving Outcomes in Participants Undergoing Gynecologic Surgery NCT03379376	Wake Forest University Health Sciences	N/A
Completed	Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations NCT02646319	Mayo Clinic	EARLY_Phase 1
Active Not Recruiting	Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymph NCT02465060	National Cancer Institute (NCI)	Phase 2